Shifting Policies on Vaccine Patents

This chapter explores the Biden administration's evolving support for a waiver on intellectual property rights for COVID-19 vaccines, marking a significant policy shift. It discusses the implications for pharmaceutical companies and the potential challenges in international negotiations at the WTO. The chapter also highlights the complex interplay between patent protections, vaccine distribution to poorer nations, and the ethical considerations involved in global health access.